ETF Holdings Breakdown of PGEN

PGEN institutional holdings

The following institutional investment holdings of PGEN have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-12	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	196,216	USD 788,788	4.02
2025-11-12	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	196,216 0.3%	USD 788,788 1.7%	4.02
Total =		392,432	USD 1,577,576

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with PGEN

Precigen (NASDAQ:PGEN) Director Randal Kirk Sells 3,596,892 Shares

Precigen, Inc. (NASDAQ:PGEN – Get Free Report) Director Randal Kirk sold 3,596,892 shares of the business’s stock in a transaction dated Friday, September 19th. The stock was sold at an average price of $3.68, for a total value of $13,236,562.56. Following the sale, the director owned 8,520,537 shares in the company, valued at approximately $31,355,576.16. […] - 2025-09-21 05:55:03

Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 1,403,360 Shares of Stock

Precigen, Inc. (NASDAQ:PGEN – Get Free Report) Director Randal Kirk sold 1,403,360 shares of Precigen stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $3.86, for a total value of $5,416,969.60. Following the sale, the director directly owned 12,117,429 shares of the company’s stock, valued at $46,773,275.94. […] - 2025-09-21 05:55:02

Analysts Set Precigen, Inc. (NASDAQ:PGEN) PT at $8.25

Shares of Precigen, Inc. (NASDAQ:PGEN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price objective […] - 2025-09-16 02:14:58

Precigen Target of Unusually High Options Trading (NASDAQ:PGEN)

Precigen, Inc. (NASDAQ:PGEN – Get Free Report) saw some unusual options trading on Thursday. Investors acquired 18,255 call options on the company. Thisrepresentsanincreaseofapproximately379% compared to the typical daily volume of 3,812 call options. Institutional Investors Weigh In On Precigen A number of institutional investors and hedge funds have recently added to or reduced their stakes […] - 2025-08-22 05:07:31

Precigen (NASDAQ:PGEN) Stock Price Up 10.9% Following Analyst Upgrade

Shares of Precigen, Inc. (NASDAQ:PGEN – Get Free Report) shot up 10.9% during mid-day trading on Tuesday after JMP Securities raised their price target on the stock from $6.00 to $8.00. JMP Securities currently has a market outperform rating on the stock. Precigen traded as high as $3.34 and last traded at $3.27. 6,747,803 shares […] - 2025-08-21 02:25:51

Precigen (NASDAQ:PGEN) Trading 7.5% Higher After Earnings Beat

Precigen, Inc. (NASDAQ:PGEN – Get Free Report) shares traded up 7.5% on Wednesday following a stronger than expected earnings report. The company traded as high as $1.99 and last traded at $1.94. 1,864,505 shares changed hands during trading, a decline of 7% from the average session volume of 1,996,835 shares. The stock had previously closed […] - 2025-08-15 02:52:48

Precigen (NASDAQ:PGEN) Stock Rating Upgraded by Wall Street Zen

Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday. Several other brokerages have also commented on PGEN. HC Wainwright reaffirmed a “buy” rating and issued a $6.00 price target on […] - 2025-07-14 03:30:50

Precigen, Inc. (NASDAQ:PGEN) Shares Sold by D. E. Shaw & Co. Inc.

D. E. Shaw & Co. Inc. cut its holdings in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) by 65.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 424,900 shares of the biotechnology company’s stock after selling 792,731 shares during the quarter. D. E. […] - 2025-05-26 04:44:50

Analyzing Precigen (NASDAQ:PGEN) & Biofrontera (NASDAQ:BFRI)

Biofrontera (NASDAQ:BFRI – Get Free Report) and Precigen (NASDAQ:PGEN – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends. Insider & Institutional Ownership 10.1% of Biofrontera shares are […] - 2025-05-12 03:14:55

Precigen, Inc. (NASDAQ:PGEN) Given Average Rating of “Moderate Buy” by Analysts

Precigen, Inc. (NASDAQ:PGEN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. The average 1-year target price among brokerages that […] - 2025-02-19 05:06:52

Back to Listing

Disclaimer